Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
ZTS

ZTS - Zoetis Inc Stock Price, Fair Value and News

179.91USD-0.85 (-0.47%)Market Closed

Market Summary

ZTS
USD179.91-0.85
Market Closed
-0.47%

ZTS Stock Price

View Fullscreen

ZTS RSI Chart

ZTS Valuation

Market Cap

82.1B

Price/Earnings (Trailing)

34.33

Price/Sales (Trailing)

9.4

EV/EBITDA

23.32

Price/Free Cashflow

46.91

ZTS Price/Sales (Trailing)

ZTS Profitability

EBT Margin

34.19%

Return on Equity

47.27%

Return on Assets

16.66%

Free Cashflow Yield

2.13%

ZTS Fundamentals

ZTS Revenue

Revenue (TTM)

8.7B

Rev. Growth (Yr)

9.5%

Rev. Growth (Qtr)

-1.04%

ZTS Earnings

Earnings (TTM)

2.4B

Earnings Growth (Yr)

8.51%

Earnings Growth (Qtr)

14.1%

Breaking Down ZTS Revenue

Last 7 days

0.7%

Last 30 days

5.3%

Last 90 days

13.6%

Trailing 12 Months

-4.6%

How does ZTS drawdown profile look like?

ZTS Financial Health

Current Ratio

3.33

Debt/Equity

1.3

Debt/Cashflow

0.37

ZTS Investor Care

Dividend Yield

0.9%

Dividend/Share (TTM)

1.61

Buy Backs (1Y)

1.26%

Diluted EPS (TTM)

5.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20248.7B000
20238.1B8.2B8.4B8.5B
20227.9B8.0B8.0B8.1B
20217.0B7.4B7.6B7.8B
20206.3B6.3B6.5B6.7B
20195.9B6.0B6.2B6.3B
20185.4B5.6B5.7B5.8B
20175.0B5.0B5.1B5.3B
20164.8B4.9B4.9B4.9B
20154.8B4.8B4.8B4.8B
20144.6B4.6B4.7B4.8B
20134.4B4.4B4.5B4.6B
20124.3B4.3B4.3B4.3B
20113.7B3.9B4.1B4.2B
20100003.6B
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEzoetis.com
 INDUSTRYPharmaceuticals
 EMPLOYEES13800

Zoetis Inc Frequently Asked Questions


What is the ticker symbol for Zoetis Inc? What does ZTS stand for in stocks?

ZTS is the stock ticker symbol of Zoetis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zoetis Inc (ZTS)?

As of Fri Jul 26 2024, market cap of Zoetis Inc is 82.09 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZTS stock?

You can check ZTS's fair value in chart for subscribers.

Is Zoetis Inc a good stock to buy?

The fair value guage provides a quick view whether ZTS is over valued or under valued. Whether Zoetis Inc is cheap or expensive depends on the assumptions which impact Zoetis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZTS.

What is Zoetis Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, ZTS's PE ratio (Price to Earnings) is 34.33 and Price to Sales (PS) ratio is 9.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZTS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zoetis Inc's stock?

In the past 10 years, Zoetis Inc has provided 0.192 (multiply by 100 for percentage) rate of return.